Tania Perrone

545 total citations
23 papers, 410 citations indexed

About

Tania Perrone is a scholar working on Surgery, Oncology and Physiology. According to data from OpenAlex, Tania Perrone has authored 23 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 7 papers in Oncology and 5 papers in Physiology. Recurrent topics in Tania Perrone's work include Nausea and vomiting management (10 papers), Anesthesia and Pain Management (10 papers) and Intraoperative Neuromonitoring and Anesthetic Effects (3 papers). Tania Perrone is often cited by papers focused on Nausea and vomiting management (10 papers), Anesthesia and Pain Management (10 papers) and Intraoperative Neuromonitoring and Anesthetic Effects (3 papers). Tania Perrone collaborates with scholars based in Italy, South Africa and United States. Tania Perrone's co-authors include Erminio Bonizzoni, Maurizio Musso, Valentina Elisabetta Bounous, C. Bianchini, Alessandra Crescimanno, Renato Scalone, Valentina Tuninetti, Nicoletta Biglia, Marta D’Alonzo and Fausto Petrelli and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and European Journal of Cancer.

In The Last Decade

Tania Perrone

23 papers receiving 402 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tania Perrone Italy 12 164 109 90 68 55 23 410
Alev Akyol Erikçi Türkiye 11 76 0.5× 210 1.9× 38 0.4× 27 0.4× 47 0.9× 31 540
D. J. Meiklejohn United Kingdom 9 64 0.4× 67 0.6× 52 0.6× 15 0.2× 33 0.6× 15 437
Anastasia Xourafa Italy 12 53 0.3× 77 0.7× 28 0.3× 15 0.2× 16 0.3× 24 348
Garth Beinart United States 6 162 1.0× 200 1.8× 23 0.3× 15 0.2× 14 0.3× 9 510
Doyeun Oh South Korea 15 84 0.5× 107 1.0× 21 0.2× 190 2.8× 11 0.2× 29 552
Nikki L. Neubauer United States 16 208 1.3× 85 0.8× 16 0.2× 24 0.4× 15 0.3× 23 646
Paul Kaywin United States 8 190 1.2× 65 0.6× 16 0.2× 100 1.5× 11 0.2× 10 505
Brahim Nsiri Tunisia 13 45 0.3× 20 0.2× 32 0.4× 51 0.8× 21 0.4× 36 491
Fidéline Bonnet-Serrano France 14 194 1.2× 36 0.3× 16 0.2× 10 0.1× 237 4.3× 44 449
Huub P J Willems Netherlands 5 75 0.5× 27 0.2× 32 0.4× 85 1.3× 6 0.1× 7 529

Countries citing papers authored by Tania Perrone

Since Specialization
Citations

This map shows the geographic impact of Tania Perrone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tania Perrone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tania Perrone more than expected).

Fields of papers citing papers by Tania Perrone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tania Perrone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tania Perrone. The network helps show where Tania Perrone may publish in the future.

Co-authorship network of co-authors of Tania Perrone

This figure shows the co-authorship network connecting the top 25 collaborators of Tania Perrone. A scholar is included among the top collaborators of Tania Perrone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tania Perrone. Tania Perrone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rigacci, Luigi, Umberto Restelli, Barbara Scappini, et al.. (2018). Lenograstim and filgrastim in the febrile neutropenia prophylaxis of hospitalized patients: efficacy and cost of the prophylaxis in a retrospective survey. Journal of Blood Medicine. Volume 10. 21–27. 4 indexed citations
2.
Restelli, Umberto, G. Saibene, Patrizia Nardulli, et al.. (2017). Cost-utility and budget impact analyses of the use of NEPA for chemotherapy-induced nausea and vomiting prophylaxis in Italy. BMJ Open. 7(7). e015645–e015645. 15 indexed citations
3.
Biglia, Nicoletta, et al.. (2017). Vaginal Atrophy in Breast Cancer Survivors: Attitude and Approaches Among Oncologists. Clinical Breast Cancer. 17(8). 611–617. 69 indexed citations
4.
Zecca, Ernesto, et al.. (2015). Pharmacokinetic study between a bilayer matrix fentalyl patch and a monolayer matrix fentanyl patch: single dose administration in healthy volunteers. British Journal of Clinical Pharmacology. 80(1). 110–115. 7 indexed citations
5.
Rigacci, Luigi, Benedetta Puccini, Sofya Kovalchuk, et al.. (2014). Feasibility and safety of a reduced duration of therapy of colony-stimulating factor in a dose-dense regimen. Supportive Care in Cancer. 22(9). 2557–2561. 2 indexed citations
6.
Barni, Sandro, Fausto Petrelli, Erminio Bonizzoni, et al.. (2014). Survival benefit with low-molecular-weight heparin in patients with advanced solid tumors: A post hoc analysis of PROTECHT trial.. Journal of Clinical Oncology. 32(15_suppl). 9640–9640. 3 indexed citations
7.
8.
Lolli, Ivan, Maria Grazia Fabrini, Giovanni Silvano, et al.. (2012). A retrospective pooled analysis of response patterns and risk factors in recurrent malignant glioma patients receiving a nitrosourea-based chemotherapy. Journal of Translational Medicine. 10(1). 90–90. 10 indexed citations
9.
Lorusso, Vito, et al.. (2012). Antiemetic efficacy of single-dose palonosetron and dexamethasone in patients receiving multiple cycles of multiple day-based chemotherapy. Supportive Care in Cancer. 20(12). 3241–3246. 12 indexed citations
10.
Rigacci, Luigi, Benedetta Puccini, Renato Alterini, et al.. (2011). Single dose palonosetron and dexamethasone in preventing nausea and vomiting induced by high emetogenic ABVD regimen in Hodgkin Lymphoma patients. Leukemia Research. 36(2). 182–185. 9 indexed citations
11.
Barni, Sandro, Roberto Labianca, Giancarlo Agnelli, et al.. (2011). Chemotherapy-associated thromboembolic risk in cancer outpatients and effect of nadroparin thromboprophylaxis: results of a retrospective analysis of the PROTECHT study. Journal of Translational Medicine. 9(1). 179–179. 79 indexed citations
12.
13.
14.
Vecchio, Michele Del, Roberta Mortarini, Stefania Canova, et al.. (2010). Bevacizumab plus Fotemustine as First-line Treatment in Metastatic Melanoma Patients: Clinical Activity and Modulation of Angiogenesis and Lymphangiogenesis Factors. Clinical Cancer Research. 16(23). 5862–5872. 44 indexed citations
15.
Musso, Maurizio, et al.. (2009). Palonosetron and dexamethasone for prevention of nausea and vomiting in patients receiving high-dose chemotherapy with auto-SCT. Bone Marrow Transplantation. 45(1). 123–127. 22 indexed citations
16.
17.
Musso, Maurizio, Renato Scalone, Gianpaolo Marcacci, et al.. (2009). Fotemustine plus etoposide, cytarabine and melphalan (FEAM) as a new conditioning regimen for lymphoma patients undergoing auto-SCT: a multicenter feasibility study. Bone Marrow Transplantation. 45(7). 1147–1153. 31 indexed citations
18.
Musso, Maurizio, et al.. (2008). Palonosetron (Aloxi®) and dexamethasone for the prevention of acute and delayed nausea and vomiting in patients receiving multiple-day chemotherapy. Supportive Care in Cancer. 17(2). 205–209. 34 indexed citations
19.
Longeri, M., et al.. (2003). Survival motor neuron (SMN) polymorphism in relation to congenital arthrogryposis in two Piedmont calves (piemontese). Genetics Selection Evolution. 35(S1). S167–75. 3 indexed citations
20.
Longeri, M., et al.. (2003). Survival motor neuron (SMN) polymorphism in relation tocongenital arthrogryposis in two Piedmont calves (piemontese). Genetics Selection Evolution. 35(Suppl. 1). S167–S175. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alev Akyol Erikçi Breakdown of academic impact, for papers by D. J. Meiklejohn Breakdown of academic impact, for papers by Anastasia Xourafa Breakdown of academic impact, for papers by Garth Beinart Breakdown of academic impact, for papers by Doyeun Oh Breakdown of academic impact, for papers by Nikki L. Neubauer Breakdown of academic impact, for papers by Paul Kaywin Breakdown of academic impact, for papers by Brahim Nsiri Breakdown of academic impact, for papers by Fidéline Bonnet-Serrano Breakdown of academic impact, for papers by Huub P J Willems
Rankless by CCL
2026